Cargando…
Comprehensive integrative profiling of upper tract urothelial carcinomas
BACKGROUND: Crosstalk between genetic, epigenetic, and immune alterations in upper tract urothelial carcinomas and their role in shaping muscle invasiveness and patient outcome are poorly understood. RESULTS: We perform an integrative genome- and methylome-wide profiling of diverse non-muscle-invasi...
Autores principales: | Su, Xiaoping, Lu, Xiaofan, Bazai, Sehrish Khan, Compérat, Eva, Mouawad, Roger, Yao, Hui, Rouprêt, Morgan, Spano, Jean-Philippe, Khayat, David, Davidson, Irwin, Tannir, Nizar N., Yan, Fangrong, Malouf, Gabriel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780630/ https://www.ncbi.nlm.nih.gov/pubmed/33397444 http://dx.doi.org/10.1186/s13059-020-02230-w |
Ejemplares similares
-
Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas
por: Malouf, Gabriel G., et al.
Publicado: (2016) -
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma
por: Flippot, Ronan, et al.
Publicado: (2017) -
Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions
por: Thouvenin, Jonathan, et al.
Publicado: (2021) -
Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021) -
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
por: Lu, Xiaofan, et al.
Publicado: (2023)